Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / GLYC - GlycoMimetics: Is No News Bad News?

GLYC - GlycoMimetics: Is No News Bad News?

GlycoMimetics Inc.

2024-04-30 07:42:14 ET

Summary

  • GlycoMimetics is a biotech company focusing on developing a targeted therapy for acute myeloid leukemia.
  • GLYC's lead candidate, uproleselan, has shown promising results in early-stage clinical trials for relapsed/refractory AML.
  • The company is approaching a critical phase 3 data readout for uproleselan, which could significantly impact its valuation and potential for approval.

...

For further details see:

GlycoMimetics: Is No News Bad News?
Stock Information
Company Name: GlycoMimetics Inc.
Stock Symbol: GLYC
Market: NASDAQ
Website: glycomimetics.com
Menu
GLYC GLYC Quote GLYC Short GLYC News GLYC Articles GLYC Message Board
Get GLYC Alerts

News, Short Squeeze, Breakout and More Instantly...